betamethasone valerate 0.1% / clioquinol 3% cream
de pharmaceuticals - clioquinol; betamethasone valerate - cutaneous cream - 30mg/1gram ; 1mg/1gram
betamethasone valerate 0.1% / clioquinol 3% cream
cst pharma ltd - clioquinol; betamethasone valerate - cutaneous cream - 30mg/1gram ; 1mg/1gram
betamethasone valerate 0.1% / clioquinol 3% cream
pilsco ltd - clioquinol; betamethasone valerate - cutaneous cream - 30mg/1gram ; 1mg/1gram
betamethasone valerate 0.1% / clioquinol 3% cream
medihealth (northern) ltd - clioquinol; betamethasone valerate - cutaneous cream - 30mg/1gram ; 1mg/1gram
clioquinol 3% / coal tar 3% in betamethasone valerate 0.025% ointment
special order - clioquinol; coal tar; betamethasone valerate - cutaneous ointment - 30mg/1gram ; 30mg/1gram ; 235microgram/1gram
betnovate-c cream
chemidex pharma ltd - betamethasone valerate; clioquinol - cutaneous cream - 1mg/1gram ; 30mg/1gram
betnovate lotion 0.1 %
wael pharmacy - betamethasone 17-valerate, betamethasone valerate, clioquinol - lotion - 0.1
betnovate scalp solution 0.1 %
wael pharmacy - betamethasone 17-valerate, betamethasone valerate, clioquinol - scalp solution - 0.1
betamethasone dipropionate cream
actavis pharma, inc. - betamethasone dipropionate (unii: 826y60901u) (betamethasone - unii:9842x06q6m) - betamethasone 0.5 mg in 1 g - betamethasone dipropionate cream is a medium-potency corticosteroid indicated for relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses in patients 13 years and older. betamethasone dipropionate cream is contraindicated in patients who are hypersensitive to betamethasone dipropionate, to other corticosteroids, or to any ingredient in this preparation.
betamethasone dipropionate- betamethasone dipropionate ointment
preferred pharmaceuticals, inc - betamethasone dipropionate (unii: 826y60901u) (betamethasone - unii:9842x06q6m) - betamethasone 0.5 mg in 1 g - betamethasone dipropionate ointment is a high-potency corticosteroid indicated for relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses in patients 13 years and older. betamethasone dipropionate ointment is contraindicated in patients who are hypersensitive to betamethasone dipropionate, to other corticosteroids, or to any ingredient in these preparations.